NCT00767221: Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study |
|
|
| Completed | 2 | 20 | Europe | Budesonide, Nefecon, PL-56 (topical acting, anti-inflammatory agent) | Calliditas Therapeutics AB, Archimedes Development Ltd | IGA Nephropathy | 11/08 | 11/08 | | |
